Wave Life Sciences | 4: Statement of changes in beneficial ownership of securities-Officer Moran Kyle
Wave Life Sciences | 144: Notice of proposed sale of securities pursuant to Rule 144
Wave Life Sciences | 10-K: Annual report
Wave Life Sciences | 8-K: Wave Life Sciences Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
Wave Life Sciences | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Maverick Capital, Ltd.(6.9%),Maverick Capital Management, LLC(6.9%), etc.
Wave Life Sciences | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-683 Capital Management, LLC(4.7%),683 Capital Partners, LP(4.7%), etc.
Wave Life Sciences | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-BB Biotech AG(3.7%),Biotech Target N.V.(3.7%)
Wave Life Sciences | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-M28 Capital Management LP(6.0%),Marc Elia(6.0%)
Wave Life Sciences | 4: Statement of changes in beneficial ownership of securities-Officer Francis Chris
Wave Life Sciences | 4: Statement of changes in beneficial ownership of securities-Officer BOLNO PAUL
Wave Life Sciences | 4: Statement of changes in beneficial ownership of securities-Officer Moran Kyle
Wave Life Sciences | 4: Statement of changes in beneficial ownership of securities-Officer Vargeese Chandra
Wave Life Sciences | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Adage Capital Partners, L.P.(5.03%),Adage Capital Partners GP, L.L.C.(5.03%), etc.
Wave Life Sciences | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-GSK plc(11.5%)
Wave Life Sciences | 4: Statement of changes in beneficial ownership of securities-10% Owner GSK plc
Wave Life Sciences | 4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-Director RA CAPITAL MANAGEMENT, L.P.
Wave Life Sciences | 8-K: Current report
Wave Life Sciences | 8-K: Current report
Wave Life Sciences | 8-K: Current report
Wave Life Sciences | 4: Statement of changes in beneficial ownership of securities-Director RA CAPITAL MANAGEMENT, L.P.
No Data